The firm has multiple catalysts that could generate a rally of 35% for the stock.
Arbutus Biopharma and Genevant have expanded their patent infringement actions against Pfizer and BioNTech by adding new ...
A quarter that produced a surprise profit and a bigger 2026 forecast is sending Moderna (NASDAQ:MRNA | MRNA Price Prediction) ...
GSK stock is in focus after a Hague court upheld a key vaccine patent against Pfizer and BioNTech. The ruling could ...
The same pair also filed additional patent suits in Japan against Pfizer Japan, again pursuing compensation and injunctive relief. BioNTech is named as a defendant in the expanded Canadian action, ...
BioNTech (BNTX) ADRs lost ~5% in the premarket on Thursday after Bloomberg News reported that Pfizer (PFE) is planning to sell its remaining stake in its partner, which helped the U.S. pharma giant to ...
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results